Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Keegan, Richard Zakour, Joel Schaefer

Seahorse Bioscience, a developer of cellular analysis tools, has appointed Joseph Keegan to its board of directors. Keegan was previously CEO of Molecular Devices. Prior to that, he was president of worldwide tissue culture at Becton Dickinson and vice president of Leica’s microscopy and scientific instruments division.
 

 
The Tech Council of Maryland has tapped Richard Zakour to be executive director of MdBio and the MdBio Foundation. Zakour was formerly general manager of Fisher BioSciences and previously was in management at McKesson Clinical Services, DynCorp and Cambridge Biotech. Zakour was a member of TCM’s board of directors between 2003 until early 2007 and he served on MdBio Foundation’s board as well.
 

 
Xceleron this week said it has appointed Joel Schaefer to be senior director of business development. Schaefer held the same title at MDS Pharma, and he has worked for the past four years providing development support in the European, Asian, and North American biotech and pharmaceutical markets. Schaefer also has worked at Otsuka, Johnson & Johnson, and at Boehringer-Ingelheim.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.